Literature DB >> 22334169

Serum creatine kinase after exercise: drawing the line between physiological response and exertional rhabdomyolysis.

Kimbra Kenney1, Mark E Landau, Rodney S Gonzalez, Julie Hundertmark, Karen O'Brien, William W Campbell.   

Abstract

INTRODUCTION: In this investigation we assessed the spectrum of creatine kinase (CK) responses in military recruits undergoing basic training.
METHODS: Musculoskeletal examination data, questionnaire findings, and CK levels were obtained from 499 recruits at days 0, 3, 7, and 14 of training. Correlations of CK with ethnicity, age, body mass index, exercise, muscle pain, and climate were obtained.
RESULTS: None of the subjects developed clinical exertional rhabdomyolysis (ER). The mean/median serum CK values were 223/157, 734/478, 1226/567, and 667/486 IU/L at days 0, 3, 7, and 14, respectively, with a wide overall range (34-35,056 IU/L). African-American subjects had higher mean CK levels.
CONCLUSIONS: CK elevations and muscle pain are common during basic training. Widely accepted laboratory diagnostic values for ER are routinely exceeded in this military recruits, suggesting that CK levels >50 times the upper limit of normal are more specific. The findings support using CK as a marker for ER. Normal laboratory reference ranges for CK should be published by ethnicity.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22334169     DOI: 10.1002/mus.22317

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  23 in total

1.  Rhabdomyolysis. The role of diagnostic and prognostic factors.

Authors:  Eran Keltz; Fahmi Yousef Khan; Gideon Mann
Journal:  Muscles Ligaments Tendons J       Date:  2014-02-24

2.  Genetic polymorphisms associated with exertional rhabdomyolysis.

Authors:  Patricia A Deuster; Carmen L Contreras-Sesvold; Francis G O'Connor; William W Campbell; Kimbra Kenney; John F Capacchione; Mark E Landau; Sheila M Muldoon; Elisabeth J Rushing; Yuval Heled
Journal:  Eur J Appl Physiol       Date:  2013-03-31       Impact factor: 3.078

3.  The Diagnosis and Treatment of Antisynthetase Syndrome.

Authors:  Leah J Witt; James J Curran; Mary E Strek
Journal:  Clin Pulm Med       Date:  2016-09

4.  Single- and multiple-dose safety, tolerability, pharmacokinetic, and pharmacodynamic profiles of ASP0367, or bocidelpar sulfate, a novel modulator of peroxisome proliferator-activated receptor delta in healthy adults: Results from a phase 1 study.

Authors:  Mototsugu Ito; Sitra Tauscher-Wisniewski; Ronald A Smulders; Tomasz Wojtkowski; Akihiro Yamada; Akira Koibuchi; Tolga Uz; Gerard J Marek; Ronald D Goldwater
Journal:  Muscle Nerve       Date:  2021-10-28       Impact factor: 3.852

5.  A randomized controlled trial of exercise in spinal and bulbar muscular atrophy.

Authors:  Joseph A Shrader; Ilona Kats; Angela Kokkinis; Cris Zampieri; Ellen Levy; Galen O Joe; Joshua G Woolstenhulme; Bart E Drinkard; Michaele R Smith; Willie Ching; Laboni Ghosh; Derrick Fox; Sungyoung Auh; Alice B Schindler; Kenneth H Fischbeck; Christopher Grunseich
Journal:  Ann Clin Transl Neurol       Date:  2015-05-07       Impact factor: 4.511

6.  Exertional rhabdomyolysis in the athlete: a clinical review.

Authors:  David C Tietze; James Borchers
Journal:  Sports Health       Date:  2014-07       Impact factor: 3.843

7.  Creatine Phosphokinase Values during Low Starting Dose Isotretinoin Therapy.

Authors:  Marco Manfredini; Vincenzo Bettoli; Riccardo Forconi; Lucrezia Pacetti; Francesca Farnetani; Monica Corazza; Giovanni Pellacani
Journal:  Skin Appendage Disord       Date:  2020-05-05

8.  CrossFit-Induced Rhabdomyolysis in a Young Healthy Indonesian Male.

Authors:  Sherly Lawrensia; Joshua Henrina; Alius Cahyadi
Journal:  Cureus       Date:  2021-04-27

9.  Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA.

Authors:  Thomas L Richie; Yupin Charoenvit; Ruobing Wang; Judith E Epstein; Richard C Hedstrom; Sanjai Kumar; Thomas C Luke; Daniel A Freilich; Joao C Aguiar; John B Sacci; Martha Sedegah; Ronald A Nosek; Patricia De La Vega; Mara P Berzins; Victoria F Majam; Esteban N Abot; Harini Ganeshan; Nancy O Richie; Jo Glenna Banania; Maria Fe B Baraceros; Tanya G Geter; Robin Mere; Lolita Bebris; Keith Limbach; Bradley W Hickey; David E Lanar; Jennifer Ng; Meng Shi; Peter M Hobart; Jon A Norman; Lorraine A Soisson; Michael R Hollingdale; William O Rogers; Denise L Doolan; Stephen L Hoffman
Journal:  Hum Vaccin Immunother       Date:  2012-11-01       Impact factor: 3.452

10.  THE COMBINATION OF α-LIPOIC ACID INTAKE WITH ECCENTRIC EXERCISE MODULATES ERYTHROPOIETIN RELEASE.

Authors:  B Morawin; D Turowski; M Naczk; I Siatkowski; A Zembron-Lacny
Journal:  Biol Sport       Date:  2014-07-15       Impact factor: 2.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.